CBIZ INSURANCE SERVICES, INC. – Trademark Portfolio
Entity Type: 03
CBIZ INSURANCE SERVICES, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 10 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ADPLAN, MCRAIL, SLATON, PAY AS YOU PLAY, and WE COVER SPORTS. The owner is based in CUMBERLAND, MD.
44 BALTIMORE STREET
CUMBERLAND, MD 21502
Showing of trademarks Trademarks
Trademark Classifications
CBIZ INSURANCE SERVICES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does CBIZ INSURANCE SERVICES, INC. have?
CBIZ INSURANCE SERVICES, INC. has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 cancelled.
What trademark classes does CBIZ INSURANCE SERVICES, INC. file in?
CBIZ INSURANCE SERVICES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are CBIZ INSURANCE SERVICES, INC.'s most well-known trademarks?
CBIZ INSURANCE SERVICES, INC.'s registered trademark portfolio includes well-known marks such as ADPLAN, MCRAIL, SLATON, PAY AS YOU PLAY, and WE COVER SPORTS. These are among 6 currently registered trademarks in the portfolio.
What is CBIZ INSURANCE SERVICES, INC.'s trademark registration success rate?
CBIZ INSURANCE SERVICES, INC. has a 60% trademark registration rate, with 6 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.